WARRANTS (Details) - Schedule of Warrant Activity - $ / shares |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2023 |
Dec. 31, 2022 |
Dec. 31, 2021 |
|
| Class of Warrant or Right [Line Items] | |||
| Shares outstanding and exercisable, ending | 173,200 | 321,200 | 540,000 |
| Weighted Average Exercise Price outstanding and exercisable, ending (in Dollars per share) | $ 0.25 | $ 0.25 | $ 0.31 |
| Weighted Average Remaining Contractual Life (Years) outstanding and exercisable, ending | 33 years | 1 year 3 months 25 days | 1 year 11 months 26 days |
| Exercised [Member] | |||
| Class of Warrant or Right [Line Items] | |||
| Exercised, shares | (148,000) | (118,800) | |
| Expired [Member] | |||
| Class of Warrant or Right [Line Items] | |||
| Expired, shares | (100,000) | ||
| X | ||||||||||
- Definition Share based compensation arrangement by share Based payment award options outstanding. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|